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Abstract
Background: Possible single nucleotide polymorphism (SNP) interactions in breast cancer are usually not investigated in
genome-wide association studies. Previously, we proposed a particle swarm optimization (PSO) method to compute these
kinds of SNP interactions. However, this PSO does not guarantee to find the best result in every implement, especially when
high-dimensional data is investigated for SNP–SNP interactions.
Methodology/Principal Findings: In this study, we propose IPSO algorithm to improve the reliability of PSO for the
identification of the best protective SNP barcodes (SNP combinations and genotypes with maximum difference between
cases and controls) associated with breast cancer. SNP barcodes containing different numbers of SNPs were computed. The
top five SNP barcode results are retained for computing the next SNP barcode with a one-SNP-increase for each processing
step. Based on the simulated data for 23 SNPs of six steroid hormone metabolisms and signalling-related genes, the
performance of our proposed IPSO algorithm is evaluated. Among 23 SNPs, 13 SNPs displayed significant odds ratio (OR)
values (1.268 to 0.848; p,0.05) for breast cancer. Based on IPSO algorithm, the jointed effect in terms of SNP barcodes with
two to seven SNPs show significantly decreasing OR values (0.84 to 0.57; p,0.05 to 0.001). Using PSO algorithm, two to four
SNPs show significantly decreasing OR values (0.84 to 0.77; p,0.05 to 0.001). Based on the results of 20 simulations, medians
of the maximum differences for each SNP barcode generated by IPSO are higher than by PSO. The interquartile ranges of
the boxplot, as well as the upper and lower hinges for each n-SNP barcode (n=3,10) are more narrow in IPSO than in PSO,
suggesting that IPSO is highly reliable for SNP barcode identification.
Conclusions/Significance: Overall, the proposed IPSO algorithm is robust to provide exact identification of the best
protective SNP barcodes for breast cancer.
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Introduction
Genome-wide association studies (GWAS) can identify several
highly robust and statistically significant single nucleotide
polymorphisms (SNPs) associated with breast cancer susceptibility
[1–6]. The associations for genotype frequencies of case and
control data have significant impacts on the disease susceptibility.
Although GWASs provide representative SNPs from the entire
genome, many SNPs with a low or marginal significance are
frequently excluded to effectively retrieve highly significant and
representative tagSNPs.
A steroid hormone metabolism and signalling-related genes are
implicated in the pathogenesis of breast cancer [7–12]. Several
single nucleotide polymorphism (SNP) association studies involved
these genes, such as the estrogen receptor 1 (ESR1), steroid
sulfatase (microsomal), isozyme S (STS), cytochrome P450, family
19, subfamily A, polypeptide 1 (CYP19A1), progesterone receptor
(PGR), catechol-O-methyltransferase (COMT), and sex hormone-
binding globulin (SHBG), have all been reported in these studies
[13–15].
Many studies hypothesize that the cancer or disease risk is
associated with the co-occurrence of SNPs displaying a jointed
effect [16–22]. In recent breast cancer association studies, further
evidence for SNP-SNP interactions has been identified, such as
the SNP-SNP interactions of genes related to DNA repair
[23,24], chemokine ligand-receptor interactions [25], and estro-
gen-response gene [6]. However, the possible SNP-SNP interac-
tions between these hormone metabolisms and signalling-related
genes have hardly been addressed. This is in part due to the
computationally challenging nature of association studies with
multiple SNP candidates.
Currently, analysis of SNP-SNP interactions remains challenge
because of the complex combination of data with huge SNPs.
Many possible combinations of alleles in SNP-SNP interactions
are generated when multiple SNPs are evaluated simultaneously.
Mathematically, the possible combinations of SNP interactions
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M=N!/[M!
(N-M)!]*3
M, where N is the number of SNPs or factors, and M is
the selected prediction number of SNPs. Many artificial intelli-
gence methods have been proposed to compute the association of
genotype frequencies of case and control data. They were
demonstrated to be effective in reducing the number of search
items among a greater number of SNP combinations, such as
multifactor dimensionality reduction (MDR) [26,27], polymor-
phism interaction analysis (PIA) [28], support vector machine
(SVM) [29], particle swarm optimization (PSO) [30], and genetic
algorithm (GA) [31]. In general, MDR provides many useful
features but tends to yield false positive and negative errors when
the case/control ratio in a combination of genotypes is similar to
the ratio in the entire data set [32]. The PSO and GA methods
have the ability to generate relevant SNP combinations in high-
dimensional data; however, these methods do not guarantee that
every implemented result contains a relevant solution when the
dimensionality is very high. This is due to the PSO and GA
algorithms using random generator initial values and a set number
of iterations. Accordingly, the improved algorithms for solving this
complex interaction problem are essential.
Here, we develop an improved PSO algorithm called IPSO that
improves the reliability of traditional PSO. This improvement is
based on the population initialization step during the PSO process,
i.e., keeping good solutions and improving always the concept of
best solution during the process; this conservation of superior
results yields better solutions for high-order SNP-SNP interactions.
We systematically evaluated the joint effects of 23 SNP combina-
tions of six steroid hormone metabolisms and signalling genes
involved in breast carcinogenesis. The SNP barcodes generated by
the IPSO algorithm were statistically evaluated by the odds ratio
and risk ratio to predict breast cancer susceptibility. The results
demonstrate that the proposed IPSO method can identify more
relevant SNP barcodes for high-dimensional data sets and
improved the reliability of the results in the 20 test runs we
conducted.
Methods
Particle Swarm Optimization
PSO is an efficient evolutionary computation learning algorithm
developed by Kennedy and Eberhart [33]. It was originally
developed to graphically mimic the unpredictable movement of
birds in a flock. The concept of PSO was designed to simulate
social behavior based on information exchange, and was designed
for practical applications. Within the problem space, each
potential solution can be seen as a particle in a swarm. Every
particle with a certain velocity can adjust its direction path
according to its own flight experience and that of its companions.
This superior strategy effectively mines the optimal regions of
complex search spaces through the interaction of individuals in a
population of particles. The basic elements of PSO are mentioned
below:
1) Population: A swarm (population) consisting of N particles.
Each particle can be regarded as a problem solution in this
study.
2) Particle position, xi: Each candidate solution can be
represented by a D-dimensional vector; the i
th particle can
be described as xi~(xi1,xi2,...,xiD), where xiD is the
position of the i
th particle with respect to the D
th dimension.
Each dimensional vector in particle position is defined by
the number of selected SNPs and the corresponding
genotypes for the associated SNPs.
3) Particle velocity, vi: The velocity of the i
th particle is
represented by vi~(vi1,vi2,...,viD), where viD is the velocity
of the i
th particle with respect to the D
th dimension. The new
locations of particles are chosen by adding vi to the
coordinate of the particle positionxi; PSO operates this
Figure 1. Population initialization using conservation of the best 5 results.
doi:10.1371/journal.pone.0037018.g001
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is limited within Vmin,Vmax ½ 
D.
4) Inertia weight, w: The inertia weight is used to control the
impact of the previous velocity of a particle on its current
velocity. This control parameter affects the trade-off
between the exploration and exploitation abilities of the
particle.
5) Individual best value, pbesti: pbesti is the position of the i
th
particle with the highest fitness value at a given iteration. It
can be currently regarded as a best solution of SNP barcodes
so far in terms of i
th particle.
6) Global best value, gbest: The best position of all pbest particles
is called global best. It can be currently regarded as a best
solution of SNP barcodes so in all particles.
7) Termination criteria: The process is stopped after the
maximum allowed number of iterations is reached.
The PSO algorithm can be divided into four steps within a
process period. First, particles are respectively initialized in a
population of random solutions. Then each particle finds its own
pbesti by comparing its current fitness to the fitness of its previous
position. In a third step, the gbest of all the particles in the
population is determined. And finally, the PSO algorithm executes
a search for optimal solutions by updating the generations. In each
generation, the position and velocity of the ith particle are updated
with pbesti and gbest of the swarm population. The update equations
can be formulated as:
vnew
id ~w|vold
id zc1|r1| pbestid{xold
id

zc2|r2| gbestd{xold
id
 ð1Þ
xnew
id ~xold
id zvnew
id ð2Þ
where w is the inertia weight. This inertia weight is a positive linear
function of time that changes with the generations; r1 and r2 are
random numbers between (0, 1), and c1 and c2 are acceleration
constants that control how far a particle moves in a single
generation. Velocities vnew
id and vold
id , respectively, denote the
velocities of the new and old particles; xold
id is the current particle
position, and xnew
id is the updated particle position. The velocity
implies the degree to which a particle’s position should be changed
at a particular moment in time, so that it can equal that of the
global best position, i.e., the velocity of the particle flying toward
the best position. To obtain a search solution, the particles’
velocities in each dimension are limited within [Vmin, Vmax]
D, and
the particles’ positions are limited within [Xmin, Xmax]
D, thus
determining the size of the steps the particle is allowed to take
through the solution space.
Improved Particle Swarm Optimization
This study proposes a new idea to improve the stability of results
obtained with particle swarm optimization. We conserve the best
results in the each SNP barcode prediction, which allows us to
offer better results for high-order SNP-SNP interactions. The
retention of the best results in PSO is very simple and can be done
without increasing the computational complexity of the process.
The difference between IPSO and PSO is that the proposed new
idea is applied in the population initialization step during the PSO
process. The IPSO proceeds as follows: The initial population is
generated by our strategy and then the fitness values of all
individuals in the population are calculated by a fitness function.
The particles are repositioned according to their own pbest and
gbest solutions. The procedure is repeated in each successive
iteration until the termination conditions are reached.
Encoding schemes. In IPSO, every particle in a population
is associated with a solution group. We define a particle based on
Table 1. IPSO pseudo-code.
01: begin
02: find the top five 2-SNP barcodes
03: conservation of the best five results Xg;(Xg1, Xg2, …, Xg5)
04: for N=3to all numbers of SNP
05: Pi;(Xi1, Xi2, …, Xij), iM[1.n]; jM[1.d]
06: mXij ,Xj(Min, Max), iM[1.n]; jM[1.d]
07: mVij ,Vj(Min, Max), iM[1.n]; jM[1.d]
08: evaluate Pi by Eq. 5, iM[1.n]
09: find best Xg in N-SNP combinations
10: the worst five P are replaced with Xg
11: repeat PSO:
12: for each swarm Pi, i M[1.n]
13: fi r evaluate Pi by Eq. 3
14: if pbesti,fi then
15: pbesti r??fi; pbestXi rPi
16: if gbest,pbesti then
17: gbest rpbesti; gbestX rpbestXi
18: end if
19: end if
20: for each particle Pij, jM[1.d]
21: Vijrupdate Vij by Eq.1
22: Xijrupdate Xij by Eq.2
23: next j
24: next i
25: until PSO stopping criterion is met
26: conservation of the top five results Xg;(Xg1, Xg2, …, Xg5)
27: end N
28: end
doi:10.1371/journal.pone.0037018.t001
Table 2. Pseudo-code for randomly generated data.
01: begin
02: Set size=5000
03: Set number of genotype=3
04: Calculate amount of three genotypes
05: while (all SNPs are not normalized)
06: Calculate amount of each genotype
07: Calculate numbers of each normalized genotype
08: for n=1 to number of genotype
09: Randomly create numbers of each normalized genotype
10: next n
11: end while
12: end
doi:10.1371/journal.pone.0037018.t002
Improved PSO-Based SNP Barcodes in Breast Cancer
PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e37018the number of selected SNPs, and the genotype associated with the
corresponding SNPs; the SNPs cannot be repeatedly selected. The
particle encoding can thus be represented by:
where SNPi,j represents the selected SNP, Genotypei,j represents
the three possible genotypes once SNP i,j is selected, m represents
the size of the population, and n represents the number of SNPs
selected. Initial particles are randomly generated in this study. For
example, let P=(SNP3,4,8, Genotype2,1,3). In this representation of
the particle, SNP3,4,8 represents the chosen SNPs (3, 4, 8) and
Genotype2,1,3 represents the chosen genotypes (2, 1, 3). In this case,
the selected SNPs with their corresponding genotypes are
represented as (3, 2), (4, 1), and (8, 3), respectively.
Population initialization using conservation of the top five
results. The top five results in the 2-SNP barcode and in the n-
SNP barcode (n §3) are generated differently. For the 2-SNP
barcode, we only apply the exhaustive search algorithm to
compute and check all possible 2-SNP combinations to give the
best five results for all 2-SNP barcodes. To generate the n-SNP
barcode (n §3), the steps for population initialization are
illustrated in Figure 1. To initialize the population, the top five
results amongst the previous 2-SNP combinations are used to
initialize the population initialization for other numbers of SNP
combinations. For example, (SNP1,3, Genotype1,2) is one of the top
five 2-SNP barcodes (step 1-1). Subsequently, this 2-SNP barcode
is applied to search for the best combination of the 3-SNP barcode
with a maximum difference value between the case and control
data (step 2-2a); in this example the search result is (SNP1,3,i,
Genotype1,2,j), with i={2, 4, 5, 6 … n|nrepresenting the number of
SNPs} and j={1, 2, 3}. Then, the exhaustive search algorithm is
applied to compute and check all possible 3-SNP combinations to
find the top five results for all 3-SNP barcodes (step 3-3a). If the
exhaustive search algorithm finds the answer to be i=6 and j=1
(the newly added third SNP and the genotype are 6 and 1,
respectively), the best 2-SNP barcode (SNP1,3, Genotype1,2) can
generate its best 3-SNP barcode (SNP1,3,6, Genotype1,2,1). Similarly,
four of the top five 3-SNP barcodes are generated.
Meanwhile, the 3-SNP barcodes are generated in a random way
(step 2-2b) and then sorted by the order of the fitness values (step
3-3b). The result from step 3-3a is used to replace the worst of the
top five SNP barcodes (step 3-4). Finally, the updated 3-SNP
barcode population is ready for the PSO computation, in which
the top five in amongst the 3-SNP barcodes (step 3-5) are
determined. Now, the top five SNP barcodes can be used to start
the generation of the next higher order SNP barcodes. The steps
are described in detail by the annotated IPSO pseudo-code in the
next two sections.
Fitness function. In this study, the fitness value means are
used to compute the difference between the case and control data
from the selected SNP combinations. The focus lies on specific
SNP combinations to obtain the highest fitness value, i.e., the
maximum SNP combination difference between cases and
controls. The concept uses the intersection of set theory to
compute the difference between cases and controls. The intersec-
tion of two sets is the set that contains all elements of one of these
sets that also belong to the other set, but no other elements. A high
fitness value indicates the best combination of an SNP and
genotypes. The relevant equation is shown below:
F(Pi)~ n(C\Pi){n(N\Pi) jj ð 3Þ
where n represents the total number of elements in a set. C
represents the total number of SNP interactions in the case group,
and N represents the total number of SNP interactions in the
control group. Pi represents the ith particle. The fitness value
definition can be divided into three steps. First, the total number of
intersections of the case data set and the ith particle is calculated as
n(C>Pi). Second, the total number of intersections of the control
data set and the ith particle is calculated as n(N>Pi). Finally, Eq (3)
is used to calculate the fitness value that is the difference between
the intersection of the case and the particle and the intersection of
the control and the particle. For example, P=(SNP1,2, Genotype2,1)
it is used to compute the number matching the condition of the
SNP and genotypes for the case and control in the breast cancer
data. First, the number of controls for SNP1 with genotype 2 and
SNP2 with genotype 1 is calculated. The number of cases
independently matching SNP1 with genotype 2 and SNP2 with
genotype 1 was 76 in the breast cancer data set. Second, the
number of controls independently matching SNP1 with genotype 2
and SNP2 with genotype 1 is calculated as 141. According to Eq.
(3), the fitness value is determined by subtracting 76 from 141,
giving -65. If the fitness is negative, the absolute value is taken to
obtain a fitness value of 65.
Identification of pbest and gbest. Each particle finds its
personal best position (pbest) and the global best position (gbest)
when moving. If the fitness value of a particle Pi in the current
iteration is better than the fitness value of pbest in the previous
iteration, pbest is updated to that of Pi. If the fitness value of particle
Pi in the current iteration is better than gbest in the previous
iteration and is the best one in the current iteration, gbest is
updated to that of Pi. Each particle then adjusts its direction based
on pbest and gbest in the following iteration.
As mentioned in Table 1, the pseudo-code for IPSO algorithm
can collocate data with the adaptation procedure as mentioned
above and generate the best SNP barcode for breast cancer
prediction.
Parameter settings. The population size parameter was set
to 50 (Figure 1, step 2-2b). The termination condition of the PSO
is reached at a prespecified number of iterations (in our case, the
number of iterations is 100) (Figure 1, step 3-5). The other
parameters used in the PSO were c1=c2=2. Vmax was equal to
(Xmax – Xmin) and Vmin was equal to – (Xmax – Xmin). These
parameters have been optimized by Kennedy and Eberhart [33].
Performance measurement and statistical analysis. We
used five commonly used criteria to determine the performance
[28].
Correct~
TPzTN
TPzFNzFPzTN
ð4Þ
SensitivityzSpecificity~
TP
TPzFN
z
TN
FPzTN
ð5Þ
PositivePredictiveValue(PPV)zNegativePredictiveValue(NPV)
~
TP
TPzFP
z
TN
FNzTN
ð6Þ
RiskRatio~
TP|(FPzTN)
FP|(TPzFN)
ð7Þ
OddsRatio~
TP|TN
FP|FN
ð8Þ
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negatives, false negatives, and false positives, respectively. For
statistics analysis with SPSS 13.0, the risk ratio (RR) and odds ratio
(OR) are used to determine the best SNP barcode and
quantitatively measure the breast cancer risk. The boxplots were
analysed by SigmaPlot 9.0 (Systat Software, Inc.).
Table 3. Estimated effect (odds ratio and 95% CI) from individual SNPs of 23 steroid hormone metabolisms and signalling-related
genes on the occurrence of breast cancer in patients.
SNP (Gene)
a SNP
type
Case
no.
Control
no.
Odds
ratio 95% CI
p
value
e SNP (Gene)
SNP
type
Case
no.
Control
no.
Odds
ratio 95% CI
p
value
e
(Ch/position)
cd (Position)
1. rs6269 (COMT) 1-AA 1694 1769 13. rs9478249
(ESR1)
1-TT 1890 1773
(22/19949952) 2-AG 2389 2390 1.044 0.955, 1.140 0.337 (6/152199431) 2-TG 2381 2430 0.919 0.843, 1.003 0.056
3-GG 917 841 1.139 1.013, 1.279 0.028 3-GG 729 797 0.858 0.760, 0.969 0.012
2. rs4680 (COMT) 1-GG 1308 1377 14. rs1514348
(ESR1)
1-CC 1717 1830
(22/19951271) 2-GA 2440 2417 1.063 0.966, 1.169 0.211 (6/152182315) 2-CA 2435 2415 1.075 0.985, 1.173 0.107
3-AA 1252 1206 1.093 0.978, 1.221 0.118 3-AA 851 755 1.201 1.066, 1.354 0.002
3. rs10046 (CYP19A1) 1-CC 1434 1430 15. rs532010
(ESR1)
1-TT 1848 1891
(15/51502986) 2-CT 2411 2497 0.963 0.877, 1.057 0.424 (6/152130918) 2-TC 2377 2422 1.004 0.921, 1.095 0.930
3-TT 1155 1073 1.073 0.959, 1.201 0.214 3-CC 775 687 1.154 1.021, 1.305 0.021
4. rs3020314 (ESR1) 1-CC 2147 2343 16. rs566351 (PGR) 1-TT 2062 2014
(6/152270672) 2-CT 2280 2164 1.150 1.057, 1.250 0.001 (11/100985014) 2-TC 2280 2326 0.957 0.879, 1.043 0.312
3-TT 573 493 1.268 1.107, 1.453 0.001 3-CC 658 660 0.974 0.858, 1.105 0.680
5. rs2234693 (ESR1) 1-TT 1446 1450 17. rs660149 (PGR) 1-CC 2708 2591
(6/152163335) 2-TC 2480 2524 1.015 0.925, 1.113 0.761 (11/100934314) 2-CG 1927 2042 0.903 0.831, 0.981 0.016
3-CC 1074 1026 1.065 0.961, 1.181 0.232 3-GG 365 367 0.952 0.813, 1.114 0.554
6. rs1543404 (ESR1) 1-TT 1468 1467 18. rs11571171 (PGR) 1-TT 2419 2338
(6/152428838) 2-TC 2439 2441 0.999 0.910, 1.095 0.981 (11/100974887) 2-TC 2082 2163 0.930 0.856, 1.012 0.091
3-CC 1093 1092 1.000 0.894, 1.119 1.000 3-CC 499 499 0.967 0.841, 1.110 0.626
7. rs3798577 (ESR1) 1-TT 1413 1406 19. rs500760 (PGR) 1-AA 2888 2994
(6/152421130) 2-TC 2494 2542 0.976 0.889, 1.072 0.621 (11/100909991) 2-AG 1866 1767 1.095 1.007, 1.190 0.033
3-CC 1093 1052 1.034 0.922, 1.159 0.567 3-GG 246 239 1.067 0.883, 1.290 0.508
8. rs2747652 (ESR1) 1-CC 1377 1372 20. rs858518 (SHBG) 1-TT 1693 1597
(6/152437016) 2-CT 2479 2447 1.009 0.918, 1.109 0.849 (17/7533025) 2-TC 2412 2490 0.914 0.836, 0.999 0.047
3-TT 1144 1181 0.965 0.863, 1.080 0.535 3-CC 895 913 0.925 0.823, 1.039 0.188
9. rs2077647 (ESR1) 1-AA 1383 1347 21. rs272428 (SHBG) 1-CC 1609 1523
(6/152129077) 2-AG 2449 2589 0.921 0.838, 1.012 0.087 (5/179323119) 2-CT 2438 2442 0.945 0.863, 1.035 0.225
3-GG 1168 1064 1.069 0.954, 1.198 0.242 3-TT 953 1035 0.872 0.778, 0.977 0.017
10. rs2175898 (ESR1) 1-AA 1350 1353 22. rs858524 (SHBG) 1-AA 1613 1725
(6/152196952) 2-AG 2507 2457 0.846 0.768, 0.932 0.001 (17/7511287) 2-AG 2459 2393 1.099 1.005, 1.201 0.037
3-GG 1143 1190 0.941 0.852, 1.040 0.238 3-GG 928 882 1.125 1.002, 1.264 0.044
11. rs9340799 (ESR1) 1-AA 2016 2107 23. rs2017591 (STS) 1-TT 1823 1760
(6/152163381) 2-AG 2360 2302 1.071 0.984, 1.166 0.109 (X/7158114) 2-TC 2258 2437 0.895 0.819, 0.977 0.012
3-GG 624 591 1.103 0.969, 1.257 0.133 3-CC 919 803 1.105 0.983, 1.242 0.094
12. rs1709182 (ESR1) 1-TT 1932 1988
(6/152175357) 2-TC 2326 2341 1.022 0.938, 1.114 0.618
3-CC 742 671 1.138 1.006, 1.288 0.038
aData collected from literature [14].
bData highlighted in bold text are statistically significant results.
cAll the [Ch/position], i.e., [Chromosome no./Chromosome position], information is based on ‘‘Assembly GRCh37’’.
dThe contig information is shown in SNP no. (contig accession no.) as follows: SNP 1–2 (NT_011519.10); SNPs 3 (NT_010194.17); SNPs 4–15 (NT_025741.15); SNPs 16–19
(NT_033899.8); SNPs 20–22 (NT_010718.16); SNPs 23 (NT_167197.1).
eValues with p value,0.05 are highlighted in bold fonts.
doi:10.1371/journal.pone.0037018.t003
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Data Set Preparation
The data set for the steroid hormones and their signalling and
metabolic pathways (96 SNPs for 8 genes) were obtained from the
breast cancer association study in [14]. This data set only provides
the genotype frequencies without the original raw data for the
genotypes of each SNP. In our study, we simulated the genotype
data based on the original frequencies of the data set. Using the
simulated genotype data, susceptibility to breast cancer in terms of
complex SNP-SNP interactions can be considered. However, it
does not reflect the true distribution of those SNPs in cases and
controls, and therefore results are not real. However, the original
data involves different numbers of genotypes, and hence we had to
perform normalization to make each genotype size the same in
order to allow further analysis. Our simulated data was randomly
generated and obeys the original genotype frequency in the entire
data set; the simulated data is available at http://bioinfo.kmu.edu.
tw/brca-steroid-96SNP.xlsx.
The normalization procedure is provided in the ‘‘pseudo-code
for randomly generated data’’ as shown in Table 2. For example,
we set the range size to a maximum range of 5000, and then
calculate the amount of three genotypes in each SNP. The
example of SNP4 (rs3020314) includes 4551 genotypes in the
original data, which contain 2132 for CC, 1970 for CT, and 449
for TT, respectively (the step for pseudo-code 04). In each SNP,
the percentage of each genotype is calculated, for the above
instance, 2132/4551 (46.85%) for CC, 1970/4551 (43.29%) for
CT, and 449/4551 (9.86%) for TT. Based on these percentages,
the modified data for SNP4 is obtained by multiplication of the
percentage with the amount of the entire data set, i.e.,
46.85%65000=2343 for CC, 43.28%65000=2164 for CT and
9.86%65000=493 for TT (the step for pseudo-code 05 to 11).
The simulated data for SNP4 has thus been normalized to 5000
(2343+2164+493=5000). Accordingly, all original data are
normalized to the same number in this manner.
Table 4. The best estimated protective SNP combinations on the occurrence of breast cancer as determined by IPSO.
Number of combined SNPs
(specific SNPs) SNP genotypes
Control no.
/Case no.
Difference
(specific
SNPs) Correct Sen.+Spe. PPV+NPV Risk Ratio
Odds Ratio
(p value)
2-SNP others 3596/3770 0.84
SNPs(4-19) 1-1 1404/1230 174 0.48 0.97 0.96 0.88 (,0.001
*)
3-SNP others 4301/4429 0.79
SNPs(4-19-23) 1-1-2 699/571 128 0.49 0.97 0.94 0.82 (,0.001
*)
4-SNP Others 4644/4731 0.74
SNPs(4-9-19-23) 1-2-1-2 356/269 87 0.49 0.96 0.93 0.76 (,0.001
*)
5-SNP Others 4809/4864 0.70
SNPs(3-4-9-19-23) 2-1-2-1-2 191/136 55 0.50 0.99 0.91 0.71 (0.002
*)
6-SNP Others 4911/4946 0.60
SNPs(3-4-9-13-19-23) 2-1-2-2-1-2 89/54 35 0.50 0.99 0.88 0.61 (0.004
*)
7-SNP Others 4951/4972 0.57
SNPs(3-4-9-13-19-20-23) 2-1-2-2-1-2-2 49/28 21 0.50 1.00 0.87 0.57 (0.022
*)
8-SNP Others 4971/4983 0.59
SNPs(3-4-9-12-13-19-20-23) 2-1-2-2-2-1-2-2 29/17 12 0.50 1.00 0.87 0.59 (0.103)
9-SNP Others 4986/4994 0.43
SNPs(3-4-9-12-13-14-19-20-23) 2-1-2-2-2-2-1-2-2 14/6 8 0.50 1.00 0.80 0.43 (0.115)
10-SNP Others 4994/4999 0.17
SNPs(3-4-9-12-13-14-19-20-21-23) 2-1-2-2-2-2-1-2-3-2 6/1 5 0.50 1.00 0.64 0.17 (0.125)
*The SNP combinations on the occurrence of breast cancer are significantly different (p value,0.05). Sen.; Sensitivity; Spe., specificity; PPV, positive predictive value;
NPV, negative predictive value. The meanings of the SNP and genotype numbers are provided in Table 3. For example, barcode SNPs (4-19)-genotype (1-1) is
[rs3020314-CC]-[rs500760-AA]; SNPs (4, 19, 23) with genotype 1-1-2; [rs3020314-CC]-[rs500760-AA]-[rs2017591-TC].
doi:10.1371/journal.pone.0037018.t004
Figure 2. The maximum difference between cases and controls
for PSO and IPSO on the best barcodes containing two to ten
SNPs.
doi:10.1371/journal.pone.0037018.g002
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SNPs from 6 Steroid Hormone Metabolisms and
Signalling-related Genes
Based on our simulated data, Table 3 shows the performance
(OR and 95% CI) for each SNP from 6 steroid hormone
metabolisms and signalling-related genes (COMT, CYP19A1,
ESR1, PGR, SHBG, and STS). Some SNPs (such as SNPs 4, 10,
12–15, 17, and 19–23 listed in Table 3) with certain genotypes
display a statistically significant OR (p,0.05) for breast cancer;
their OR values range from 1.268 to 0.846. The other SNPs show
no statistically significant OR for breast cancer.
Identification of the SNP-SNP Interactions with Maximum
Differences between Cases and Controls Using IPSO
Using the IPSO algorithm, the best SNP-SNP interaction is
evaluated by the difference between cases and controls for all the
SNP barcodes. After computation, the top five of the 2-SNP
barcodes can be listed in order of the difference between cases and
controls: SNPs (4-19)-genotype (1-1), SNPs (4-23)-genotype (1-2),
SNPs (4-9)-genotype (1-2), SNPs (19-23)-genotype (1-2), and SNPs
(9-23)-genotype (2-2). The differences in the number of cases and
controls for these SNP barcodes are 174, 168, 158, 150, and 146,
respectively (data not shown). In this study, as shown in Table 4,
we only select the 2-SNP barcodes with a maximum difference,
i.e., the best 1 of the 2-SNP barcode. Similarly, the n-SNP
barcodes (n=3 to 10) with maximum differences, i.e., the best for
each n-SNP barcode, are also selected (left side of Table 4).
With the conservation of the top five results, we found that the
best for n-SNP barcode contains the corresponding best (n-1)-
barcode. For example, the 3-SNP barcode contains the 2-SNP
barcode, i.e., SNPs (4-19-23)-genotypes (1-1-2) vs. SNPs (4-19)-
genotypes (1-1), where the bold letters indicate the newly selected
SNP. The 4-SNP barcode contains the 3-SNP barcode, i.e., SNPs
(4-9-19-23)-genotypes (1-2-1-2) vs. SNPs (4-19-23)-genotypes (1-1-
2).
Prediction Scores of the Best IPSO-generated SNP
Barcodes in Breast Cancer
The best n-SNP barcodes (n=3 to 10) calculated by the IPSO
algorithm are listed in Table 4 to calculate their five prediction
scores, i.e., the correctness, sensitivity+specificity, PPV+NPV, RR,
and OR, in order to evaluate the breast cancer susceptibility based
on the IPSO-generated SNP barcodes. The sensitivity and
specificity values of the respective best SNP barcodes are all
higher than 0.96, suggesting that IPSO can identify the best SNP
barcodes associated with breast cancer. The correctness and
PPV+NPV values of the respective best SNP barcodes range from
0.48 to 0.50 and 0.64 to 0.96, respectively, and the RR and OR of
the best SNP barcodes range from 0.88 to 0.17 and 0.84 to 0.17,
respectively. The SNP barcodes involving two to seven SNPs show
significantly decreasing OR values (p,0.05 to 0.001). Since the
SNP barcodes listed in Table 4 show that the control numbers are
greater than the case numbers, the SNP barcodes are regarded as
protective SNP barcodes against breast cancer.
Comparison between the Best IPSO-generated and PSO-
generated SNP Barcodes in Breast Cancer
We compare IPSO with PSO for the reliability and the ability to
identify SNP barcodes to support the advantage of the top-five
strategy. The performances of the PSO and IPSO algorithms from
20 simulation runs (see supplement Table S1 and Table S2 for
details) are compared by means of the best maximum difference
between cases and controls as shown in Figure 2. To examine the
performance in terms of the statistical differences between both
algorithms, we performed the Wilcoxon Signed-Rank test and
found that there were significant differences between cases and
controls in n-SNP barcodes (n=2 to 10) (Table S3).
The maximum differences for each SNP barcode generated by
IPSO are higher than those of PSO, suggesting that the selection
of the best protective SNP barcodes is more reliable in IPSO than
in PSO. As shown in Figure 3, the median value results suggest
that IPSO is more suitable for selecting the best SNP barcodes for
breast cancer protection. Moreover, the interquartile ranges (25th
to 75th) of the boxplot, as well as the 5th, 10th, 90th and 95th
percentiles for each n-SNP barcode (n=3 to 10), are more narrow
in the IPSO algorithm (Figure 3A) than in the PSO algorithm
(Figure 3B). These data suggest that the results of the PSO
algorithm are more unstable. In contrast, the IPSO algorithm
provides exact identification of the best SNP barcodes for breast
cancer protection. Actually, the data in Figure 3A (IPSO) are all
the same for each n-SNP (n=3 to 10), i.e., 128, 87, 55, 35, 21, 12,
8, and 5 (Table 4). The best PSO-generated n-SNP barcodes with
maximum differences between cases and controls are listed in
Figure 3. Boxplots displaying the extremes, the upper and
lower quartiles, and the median of the maximum difference
between cases and controls for (A) the IPSO algorithm and (B)
the PSO algorithm on three to ten combined SNPs over 20
runs. The boundary of the box closest to zero indicates the 25th
percentile, a line within the box marks the median, and the boundary of
the box farthest from zero indicates the 75th percentile. Error bars
above and below the boxes indicate the 90th and 10th percentiles,
respectively. The triangle symbols indicate the 95th and 5th percentiles.
doi:10.1371/journal.pone.0037018.g003
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conserved. Accordingly, the PSO-generated SNP barcodes con-
serve the selected SNPs to a lesser degree (Table 3). For example,
only one SNP in the 2-SNP barcode shows up in the 3-SNP
barcode, i.e., SNP 4 (rs3020314; Table 3), and only one SNP in
the 3-SNP barcode shows up in the 4-SNP barcode, i.e., SNP 23
(rs2017591). Therefore, an order of influence on breast cancer is
very difficult to establish from the SNPs in Table 3.
Discussion
Many association studies of cancer focused on the analysis of
risk genetic factors that influence common complex traits in terms
of commonly occurring SNPs. However, the possible protective
effects are also important for the prediction of cancer morbidity by
SNPs. Here, we analyzed the contribution of 23 SNPs from six
breast cancer related genes to generate the protective SNP
barcodes in a case-control study of 5000 cases and 5000 controls
with genotype data simulation.
The maximum difference information calculated by the IPSO
algorithm can predict the relative strength of the impact of an SNP
on breast cancer protection. For example, the difference between
controls and cases for SNP barcode [SNPs (4-19)-genotype (1-1)] is
higher than that of [SNPs (4-19-23)-genotype (1-1-2)], suggesting
that SNP 4 and SNP 19 are more associated with breast cancer
protection than SNP 23. Accordingly, an order of impact on breast
cancer for the SNPs listed in Table 3 can be arranged: SNPs 4/
19. SNP 23. SNP 9. SNP 3. SNP 13. SNP 20. SNP 12.
SNP 14. SNP 21. In this simulated breast cancer association
study, the IPSO-generated SNP barcodes involving two to seven
SNPs and two to four SNPs show significantly decreasing OR
values ranging from 0.84 to 0.57 (Table 4). In contrast, some
individual SNPs with certain genotypes display statistically
significant OR values ranging from 1.268 to 0.846 (Table 3).
Some SNPs may display different impacts on the protection of
breast cancer in terms of the individual SNPs or the combinational
SNPs. For example, some individual SNPs such as SNPs 3 and 9
are not significantly associated with breast cancer (Table 3), but
the occurrence of 4- to 10-SNP combinations including SNPs 3
and 9 shows the significant association with breast cancer (Table 4).
These data suggest that the association relationship for breast
cancer may be ignored when the SNP interaction is of no concern.
A key issue of detecting SNP-SNP interactions in genome-wide
case-control study is the computational efficiency. The computa-
tional complexity of IPSO algorithm is estimated by the objective
function computation. If there are M number of iterations and N
number of solutions (particles) in the population, then the objective
function computation has O(MN) computational complexity. The
effective feature of the top 5 strategy computation is only storing
the top 5 solutions in each iteration. If there are K solutions in the
archive, storing the solutions in the archive has O(M+K)
computational complexity. If the archive and the iteration have
the same numbers, the overall complexity of IPSO is O(MN+K).
Although the optimal parameters of PSO were demonstrated by
Kennedy and Eberhart [33], we found that the parameter
adjustments may promote better results even for large numbers
of SNPs. Firstly, the population and iterations could adjust its size
according the data size, in which the population size suggested
setting from 50 to 100 and number of iterations suggested setting
from 100 to 1000, i.e., it explores to better SNP barcodes with
large difference between cases and controls, but the computational
complexity of IPSO is also increased. Secondly, the c1 and c2 are
acceleration constants that control how far a particle moves in a
single generation, and they respectively control the exploitation
Table 5. The best estimated protective SNP combinations on the occurrence of breast cancer as determined by PSO.
Number of combined SNPs
(specific SNPs) SNP genotypes
Control no.
/Case no.
Difference
(specific
SNP) Correct Sen.+Spe. PPV+NPV Risk Ratio
Odds Ratio
(p value)
2-SNP others 3596/3770 0.84
SNPs(4-19) 1-1 1404/1230 174 0.48 0.97 0.96 0.88 (,0.001*)
3-SNP others 4427/4505 0.85
SNPs(4-22-23) 1-2-2 573/495 78 0.49 0.98 0.96 0.86 (0.013*)
4-SNP Others 4670/4728 0.81
SNPs(9-18-19-23) 2-2-1-2 330/272 58 0.49 0.99 0.95 0.82 (0.016*)
5-SNP Others 4885/4911 0.77
SNPs(3-4-12-20-23) 2-1-1-2-2 115/89 26 0.50 1.00 0.93 0.77 (0.077)
6-SNP Others 4950/4962 0.76
SNPs(12-15-17-19-21-22) 2-2-2-1-2-1 50/38 12 0.50 1.00 0.93 0.76 (0.239)
7-SNP Others 4982/4988 0.67
SNPs(2-7-14-18-19-21-23) 2-2-1-2-1-1-2 18/12 6 0.50 1.00 0.90 0.67 (0.361)
8-SNP Others 4990/4995 0.50
SNPs(9-10-11-13-17-20-21-23) 3-3-2-2-1-2-2-2 10/5 5 0.50 1.00 0.83 0.50 (0.301)
9-SNP Others 4993/4995 0.71
SNPs(1-3-4-11-14-16-18-21-22) 2-2-2-1-2-2-1-1-1 7/5 2 0.50 1.00 0.92 0.71 (0.774)
10-SNP Others 4998/4999 0.50
SNPs(1-3-5-9-10-13-18-20-21-22) 2-2-2-2-2-3-1-1-3-1 2/1 1 0.50 1.00 0.83 0.50 (1.000)
*The SNP combinations on the occurrence of breast cancer are significantly different (p value,0.05). The meanings of the SNP and genotype numbers are provided in
Table 3.
doi:10.1371/journal.pone.0037018.t005
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exploitation and exploration, the c1 and c2 are suggested the same
as 2.
Although we explored the benefit of IPSO algorithm for SNP
interaction based on the simulated breast cancer study, the IPSO
algorithm is not exclusively into breast cancer data and can be
applied to other real data sets. After running these algorithms
using another disease with the real dataset [18], e.g., osteoporosis,
we found that the IPSO algorithm again showed better
performance for selecting SNP barcodes in SNP-SNP interaction
studies than the PSO algorithm (data not shown).
IPSO can overcome the limitations imposed on computational
time for complex SNP interactions for GWAS because IPSO has
the following advantages: 1) IPSO allows robust analysis of high-
order SNP combinations for GWAS studies and generates the best
SNP barcodes; 2) IPSO is an improved evolutionary algorithm
without exhaustive search; 3) IPSO only needs two parameters for
computation without complex settings; and 4) Its computational
complexity is unaffected by the size of data sets.
In conclusion, we propose an improved PSO algorithm to
perform a powerful breast cancer association analysis in terms of
SNP-SNP interactions with 23 SNPs. Our strategy successfully
improves on the performance of traditional PSO in terms of the
reliability with a combination of more statistically significant SNPs
associated with breast cancer protection. With the help of the
IPSO algorithm, the best fitness of cases and controls can be
identified. The algorithm can potentially be applied to identify
complex SNP-SNP (gene-gene) interactions for different diseases,
even in cases where a large number of SNPs is involved in
genome-wide association studies.
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